Skip to main content

Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma

Annals of Hematology volume 93, pages 1185–1191 (2014)Cite this article

Abstract

Peripheral T cell lymphomas (PTCL) account for 10–15 % of non-Hodgkin’s lymphomas and are associated with poor prognosis. Although many prognostic factors for PTCL have been proposed, the heterogeneity of PTCL seems to be an obstacle in the establishment of clinically useful prognostic system, such as the International Prognostic Index (IPI) in diffuse large B cell lymphoma. PTCL with nodal manifestation include the HTLV-I-negative histologic subtypes of PTCL not otherwise specified (PTCL-NOS), angioimmunoblastic T cell lymphoma (AITL), and anaplastic large cell lymphoma (ALCL). As PTCL-NOS encompasses a group of similar tumors and mostly shares their clinical pictures, we retrospectively analyzed clinical data from 77 patients diagnosed with ALCL, AITL, and PTCL-NOS at Kobe City Medical Center General Hospital from May 1994 to February 2012 to identify the prognostic factor for nodal PTCL. The median age of patients was 64 years, ranging from 23 to 83 years. With a median follow-up of 50 months, 5-year overall survival (OS) was 43 %. Multivariate analysis identified high-risk IPI (hazard ratio (HR), 4.04; P = 0.015), absolute monocyte count > 0.8 × 109/L (HR, 3.44; P = 0.001), and serum concentration of IgA > 410 mg/dL (HR, 2.31; P = 0.013) as poor prognostic factors for OS. Thus, we have identified novel prognostic factors of monocyte count and serum IgA level for nodal PTCL. Although conventional prognostic models mainly reflect both tumor characteristics and host factors, the present model indicates the importance of host immune response as the unfavorable prognosis.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3

References

  1. Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26:4124–4130

    PubMed  Article  Google Scholar 

  2. The International Non-Hodgkin’s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329:987–994

    Article  Google Scholar 

  3. Gisselbrecht C, Gaulard P, Lepage E, Coiffier B, Briere J et al (1998) Prognostic significance of T-cell phenotype in aggressive non-Hodgkin’s lymphomas. Groupe d’Etudes des Lymphomes de l’Adulte (GELA). Blood 92:76–82

    CAS  PubMed  Google Scholar 

  4. Sibon D, Fournier M, Briere J, Lamant L, Haioun C et al (2012) Long-term outcome of adults with systemic anaplastic large-cell lymphoma treated within the Groupe d’Etude des Lymphomes de l’Adulte trials. J Clin Oncol 30:3939–3946

    PubMed  Article  Google Scholar 

  5. Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D et al (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103:2474–2479

    CAS  PubMed  Article  Google Scholar 

  6. Went P, Agostinelli C, Gallamini A, Piccaluga PP, Ascani S et al (2006) Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. J Clin Oncol 24:2472–2479

    CAS  PubMed  Article  Google Scholar 

  7. Gutierrez-Garcia G, Garcia-Herrera A, Cardesa T, Martinez A, Villamor N et al (2011) Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann Oncol 22:397–404

    CAS  PubMed  Article  Google Scholar 

  8. Dreyling M, Thieblemont C, Gallamini A, Arcaini L, Campo E et al (2013) ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol 24:857–877

    CAS  PubMed  Article  Google Scholar 

  9. Ishikawa T (2003) Current status of therapeutic approaches to adult T-cell leukemia. Int J Hematol 78:304–311

    PubMed  Article  Google Scholar 

  10. de Leval L, Rickman DS, Thielen C, Reynies A, Huang YL et al (2007) The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells. Blood 109:4952–4963

    PubMed  Article  Google Scholar 

  11. Zettl A, Rudiger T, Konrad MA, Chott A, Simonitsch-Klupp I et al (2004) Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations. Am J Pathol 164:1837–1848

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  12. Lenz G, Wright G, Dave SS, Xiao W, Powell J et al (2008) Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359:2313–2323

    CAS  PubMed  Article  Google Scholar 

  13. Iqbal J, Weisenburger DD, Greiner TC, Vose JM, McKeithan T et al (2010) Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood 115:1026–1036

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  14. Wilcox RA, Ristow K, Habermann TM, Inwards DJ, Micallef IN et al (2011) The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia 25:1502–1509

    CAS  PubMed  Article  Google Scholar 

  15. Wilcox RA, Ristow K, Habermann TM, Inwards DJ, Micallef IN et al (2012) The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma. Leuk Lymphoma 53:575–580

    PubMed  Article  Google Scholar 

  16. Bari A, Tadmor T, Sacchi S, Marcheselli L, Liardo EV et al (2013) Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas. Leuk Res 37:619–623

    CAS  PubMed  Article  Google Scholar 

  17. Tokunaga T, Shimada K, Yamamoto K, Chihara D, Ichihashi T et al (2012) Retrospective analysis of prognostic factors for angioimmunoblastic T-cell lymphoma: a multicenter cooperative study in Japan. Blood 119:2837–2843

    CAS  PubMed  Article  Google Scholar 

  18. Yu H, Shahsafaei A, Dorfman DM (2009) Germinal-center T-helper-cell markers PD-1 and CXCL13 are both expressed by neoplastic cells in angioimmunoblastic T-cell lymphoma. Am J Clin Pathol 131:33–41

    PubMed  Article  Google Scholar 

  19. Attygalle A, Al-Jehani R, Diss TC, Munson P, Liu H et al (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 99:627–633

    CAS  PubMed  Article  Google Scholar 

  20. Dupuis J, Boye K, Martin N, Copie-Bergman C, Plonquet A et al (2006) Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 30:490–494

    PubMed  Article  Google Scholar 

  21. Shipp MA (1994) Prognostic factors in aggressive non-Hodgkin’s lymphoma: who has “high-risk” disease? Blood 83:1165–1173

    CAS  PubMed  Google Scholar 

  22. Mourad N, Mounier N, Briere J, Raffoux E, Delmer A et al (2008) Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d’Etude des Lymphomes de l’Adulte (GELA) trials. Blood 111:4463–4470

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  23. Matsumoto Y, Horiike S, Ohshiro M, Yamamoto M, Sasaki N et al (2010) Expression of master regulators of helper T-cell differentiation in peripheral T-cell lymphoma, not otherwise specified, by immunohistochemical analysis. Am J Clin Pathol 133:281–290

    PubMed  Article  Google Scholar 

  24. Steidl C, Lee T, Shah SP, Farinha P, Han G et al (2010) Tumor-associated macrophages and survival in classic Hodgkin’s lymphoma. N Engl J Med 362:875–885

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  25. Wilcox RA, Wada DA, Ziesmer SC, Elsawa SF, Comfere NI et al (2009) Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells. Blood 114:2936–2944

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  26. Wilcox RA, Feldman AL, Wada DA, Yang ZZ, Comfere NI et al (2009) B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood 114:2149–2158

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  27. Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med 339:1506–1514

    CAS  PubMed  Article  Google Scholar 

  28. Porrata LF, Ristow K, Colgan JP, Habermann TM, Witzig TE (2012) Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin’s lymphoma. Haematologica 97:262–269

    PubMed Central  PubMed  Article  Google Scholar 

  29. Takasaki Y, Iwanaga M, Tsukasaki K, Kusano M, Sugahara K et al (2007) Impact of visceral involvements and blood cell count abnormalities on survival in adult T-cell leukemia/lymphoma (ATLL). Leuk Res 31:751–757

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from Kasahara Cancer Research Foundation.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Affiliations

  1. Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan

    Aiko Kato & Kazunari Aoki

  2. Department of Clinical Pathology, Kobe City Medical Center General Hospital, 2-1-1 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan

    Yukihiro Imai

  3. Department of Hematology, Kobe City Medical Center General Hospital, 2-1-1 Minatojima-Minamimachi, Chuo-ku, Kobe, 650-0047, Japan

    Aiko Kato, Kazunari Aoki, Sumie Tabata, Akiko Matsushita & Takayuki Ishikawa

  4. Department of Cell Therapy, Institute of Biomedical Research and Innovation, 2-2, Minatojima-minamimachi, Chuoku, Kobe, 650-0047, Japan

    Hisako Hashimoto

  5. Department of Hematology, Shinko Hospital, 1-4-7, Wakihama-cho, Chuo-ku, Kobe, 651-0072, Japan

    Takayuki Takahashi

Authors
  1. Aiko Kato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yukihiro Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kazunari Aoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sumie Tabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Akiko Matsushita
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hisako Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Takayuki Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takayuki Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aiko Kato.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kato, A., Imai, Y., Aoki, K. et al. Serum IgA level, monocyte count, and international prognostic index are independently associated with overall survival in patients with HTLV-I-negative nodal peripheral T cell lymphoma. Ann Hematol 93, 1185–1191 (2014). https://doi.org/10.1007/s00277-014-2025-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-014-2025-0

Keyword

  • IgA
  • Monocyte
  • Peripheral T cell lymphoma
  • International Prognostic Index
  • Angioimmunoblastic T cell lymphoma
  • Anaplastic large cell lymphoma